| GENFIT S.A. EO -,25 |
| Frankreich |
| Gesundheit |
| FR0004163111 / A0LGJ2 |
| XUP (Frankfurt) |
| FRA:XUP, ETR:XUP, XUP:GR |
| - |
| https://www.genfit.com/ |
|
Genfit S.A. is a BCorp™ certified biopharmaceutical company specializing in the discovery and development of therapeutic solutions for rare and life-threatening liver diseases with high unmet medical needs. As a pioneer in liver disease research wi..
>Volltext.. |
| 405.51 Mio. EUR |
| 470.85 Mio. EUR |
| 53.87 Mio. EUR |
| -17.39 Mio. EUR |
| -103.78 Mio. EUR |
| -2.08 EUR |
| 182.17 Mio. EUR |
| 115.66 Mio. EUR |
| 8.51 Mio. EUR |
| 1.28 |
| 27.7% |
| -163.5% |
| - |
| - |
| - |
| - |
| GENFIT |
| 19.10.26 |
|